On December 16, Anlinke Biotech announced the completion of Series A additional financing of nearly 50 million US dollars. Round A additional financing was led by the old shareholder Junlian Capital and the new investor Meituan Dragon Ball respectively, followed by new and old shareholders such as Lanchi Venture Capital, Yuansheng Venture Capital, Wuyuan Capital, Longpan Investment, and Runzhang Venture Capital.

Zhitongcaijing · 1d ago
On December 16, Anlinke Biotech announced the completion of Series A additional financing of nearly 50 million US dollars. Round A additional financing was led by the old shareholder Junlian Capital and the new investor Meituan Dragon Ball respectively, followed by new and old shareholders such as Lanchi Venture Capital, Yuansheng Venture Capital, Wuyuan Capital, Longpan Investment, and Runzhang Venture Capital.